Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
Conditions:   Liver Fibroses;   Cirrhosis Interventions:   Drug: Atorvastatin 20mg;   Drug: Placebo Sponsors:   Raymond Chung;   University of Texas Southwestern Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2021 Category: Research Source Type: clinical trials